State Methadone Rules Limit Medication-Assisted Treatment Access

If you or someone you love relies on methadone for opioid use disorder, the state you live in may quietly shape what other medication-assisted treatment options are actually available at your clinic.

A new study published in the Journal of Substance Use and Addiction Treatment examined more than 1,500 opioid treatment programs (OTPs) nationwide, the only facilities legally permitted to dispense methadone for opioid use disorder, and found that OTPs in states with stricter methadone regulations offer a narrower range of services than OTPs in less restrictive states.

Researchers from Rutgers University, NYU Grossman School of Medicine, and RAND analyzed 2023 data from the Mental Health and Addiction Treatment Tracking Repository, a national directory of licensed substance use disorder treatment facilities.

Why Medication-Assisted Treatment Access Varies by State

Methadone medication can only be dispensed through SAMHSA-certified OTPs, and federal rules already require daily in-person visits and place limits on take-home doses.

On top of those federal requirements, 47 states and Washington, D.C. maintain their own OTP-specific regulations, totaling 89 distinct state laws, according to prior research the study cites.

These include requirements like pharmacy licensure for OTPs, zoning restrictions on where a clinic can operate, mandatory government identification for patients, and administrative discharge policies for people who test positive on a drug screen.

The researchers grouped states into high and low restrictiveness categories based on 11 of these policies, then compared what services OTPs in each group actually offered.

What the Study Found

OTPs in highly restrictive states were significantly less likely to offer all three FDA-approved medications for opioid use disorder, meaning methadone, buprenorphine, and naltrexone together, compared with OTPs in less restrictive states (37.8 percent versus 48.8 percent).

After adjusting for other facility and state characteristics, OTPs in highly restrictive states remained significantly less likely to offer naltrexone (adjusted risk ratio 0.73) and all three medications (adjusted risk ratio 0.70).

The gap was even wider in states with policies that specifically restrict patient access, such as ID and drug-screening rules, where OTPs were roughly half as likely to offer naltrexone or all three medications as OTPs in low-restrictiveness states.

Buprenorphine told a more mixed story. Availability was actually higher overall in highly restrictive states (86.6 percent versus 80.2 percent), though it dropped in the subset of states with access-restrictive policies specifically (80.3 percent).

OTPs in highly restrictive states were also less likely to offer mental health services, contingency management, and trauma-informed counseling. Housing service availability did not differ significantly between groups.

Understanding Naltrexone in Medication-Assisted Treatment

Naltrexone works differently from methadone and buprenorphine. It blocks opioid receptors rather than activating them, and it requires a person to complete opioid detoxification before starting, which limits how quickly someone can begin treatment.

Methadone and buprenorphine, by contrast, are associated with stronger evidence for reducing overdose deaths and keeping people in treatment longer, and do not require full inpatient detox first.

The study’s authors note that lower naltrexone availability in restrictive states carries different clinical implications than a shortage of methadone or buprenorphine would, since naltrexone is generally considered a secondary option for patients who prefer it or cannot use the other medications.

What This Means for Patients Seeking Care

The researchers stopped short of saying state regulations directly cause OTPs to offer fewer services, since the study design cannot establish cause and effect. Facilities operating under stricter licensing and monitoring requirements may simply have less staff capacity left over to add services like counseling or contingency management.

Still, the pattern held even after accounting for whether a facility was nonprofit, for-profit, or government-run, and whether it accepted Medicaid or Medicare.

For patients and families, the practical takeaway is that the range of services available at a methadone clinic can depend as much on state policy as on the clinic itself.

If your OTP does not offer naltrexone, mental health counseling, or trauma-informed care alongside methadone or buprenorphine, that may reflect your state’s regulatory environment rather than a gap unique to that facility.

Finding Medical Detox and MAT Programs

If your current OTP has limited service offerings, ask directly whether naltrexone, mental health services, or counseling are available on-site or through referral, and ask what your state’s specific OTP regulations require.

Never attempt alcohol or benzodiazepine detox without medical supervision. Search detox.com’s directory to find detox centers in your area. Call 800-996-6135(Sponsored) to get in contact with a treatment specialist today.